These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
135 related articles for article (PubMed ID: 20331369)
1. Targeting adenoviruses with factor x-single-chain antibody fusion proteins. Chen CY; May SM; Barry MA Hum Gene Ther; 2010 Jun; 21(6):739-49. PubMed ID: 20331369 [TBL] [Abstract][Full Text] [Related]
2. Human full-length coagulation factor X and a GLA domain-derived 40-mer polypeptide bind to different regions of the adenovirus serotype 5 hexon capsomer. Sumarheni S; Hong SS; Josserand V; Coll JL; Boulanger P; Schoehn G; Fender P Hum Gene Ther; 2014 Apr; 25(4):339-49. PubMed ID: 24512117 [TBL] [Abstract][Full Text] [Related]
3. Coagulation factor binding orientation and dimerization may influence infectivity of adenovirus-coagulation factor complexes. Irons EE; Flatt JW; Doronin K; Fox TL; Acchione M; Stewart PL; Shayakhmetov DM J Virol; 2013 Sep; 87(17):9610-9. PubMed ID: 23804638 [TBL] [Abstract][Full Text] [Related]
4. Identification of coagulation factor (F)X binding sites on the adenovirus serotype 5 hexon: effect of mutagenesis on FX interactions and gene transfer. Alba R; Bradshaw AC; Parker AL; Bhella D; Waddington SN; Nicklin SA; van Rooijen N; Custers J; Goudsmit J; Barouch DH; McVey JH; Baker AH Blood; 2009 Jul; 114(5):965-71. PubMed ID: 19429866 [TBL] [Abstract][Full Text] [Related]
5. Substitution of adenovirus serotype 3 hexon onto a serotype 5 oncolytic adenovirus reduces factor X binding, decreases liver tropism, and improves antitumor efficacy. Short JJ; Rivera AA; Wu H; Walter MR; Yamamoto M; Mathis JM; Curiel DT Mol Cancer Ther; 2010 Sep; 9(9):2536-44. PubMed ID: 20736345 [TBL] [Abstract][Full Text] [Related]
6. Influence of coagulation factor x on in vitro and in vivo gene delivery by adenovirus (Ad) 5, Ad35, and chimeric Ad5/Ad35 vectors. Greig JA; Buckley SM; Waddington SN; Parker AL; Bhella D; Pink R; Rahim AA; Morita T; Nicklin SA; McVey JH; Baker AH Mol Ther; 2009 Oct; 17(10):1683-91. PubMed ID: 19603000 [TBL] [Abstract][Full Text] [Related]
7. Adenovirus serotype 5 hexon is critical for virus infection of hepatocytes in vivo. Kalyuzhniy O; Di Paolo NC; Silvestry M; Hofherr SE; Barry MA; Stewart PL; Shayakhmetov DM Proc Natl Acad Sci U S A; 2008 Apr; 105(14):5483-8. PubMed ID: 18391209 [TBL] [Abstract][Full Text] [Related]
9. A strategy for adenovirus vector targeting with a secreted single chain antibody. Glasgow JN; Mikheeva G; Krasnykh V; Curiel DT PLoS One; 2009 Dec; 4(12):e8355. PubMed ID: 20027223 [TBL] [Abstract][Full Text] [Related]
10. Protein structural requirements for Ca2+ binding to the light chain of factor X. Studies using isolated intact fragments containing the gamma-carboxyglutamic acid region and/or the epidermal growth factor-like domains. Persson E; Björk I; Stenflo J J Biol Chem; 1991 Feb; 266(4):2444-52. PubMed ID: 1989996 [TBL] [Abstract][Full Text] [Related]
11. Cell entry and trafficking of human adenovirus bound to blood factor X is determined by the fiber serotype and not hexon:heparan sulfate interaction. Corjon S; Gonzalez G; Henning P; Grichine A; Lindholm L; Boulanger P; Fender P; Hong SS PLoS One; 2011; 6(5):e18205. PubMed ID: 21637339 [TBL] [Abstract][Full Text] [Related]
12. Requirements for receptor engagement during infection by adenovirus complexed with blood coagulation factor X. Bradshaw AC; Parker AL; Duffy MR; Coughlan L; van Rooijen N; Kähäri VM; Nicklin SA; Baker AH PLoS Pathog; 2010 Oct; 6(10):e1001142. PubMed ID: 20949078 [TBL] [Abstract][Full Text] [Related]
13. Coagulation factor X mediates adenovirus type 5 liver gene transfer in non-human primates (Microcebus murinus). Alba R; Bradshaw AC; Mestre-Francés N; Verdier JM; Henaff D; Baker AH Gene Ther; 2012 Jan; 19(1):109-13. PubMed ID: 21677690 [TBL] [Abstract][Full Text] [Related]
14. Role of the Gla and first epidermal growth factor-like domains of factor X in the prothrombinase and tissue factor-factor VIIa complexes. Thiec F; Cherel G; Christophe OD J Biol Chem; 2003 Mar; 278(12):10393-9. PubMed ID: 12529356 [TBL] [Abstract][Full Text] [Related]
15. Lipid specificity of the membrane binding domain of coagulation factor X. Muller MP; Wang Y; Morrissey JH; Tajkhorshid E J Thromb Haemost; 2017 Oct; 15(10):2005-2016. PubMed ID: 28782177 [TBL] [Abstract][Full Text] [Related]
16. Mouse adenovirus type 1 and human adenovirus type 5 differ in endothelial cell tropism and liver targeting. Lenaerts L; McVey JH; Baker AH; Denby L; Nicklin S; Verbeken E; Naesens L J Gene Med; 2009 Feb; 11(2):119-27. PubMed ID: 19065608 [TBL] [Abstract][Full Text] [Related]
17. Retargeting of adenovirus vectors through genetic fusion of a single-chain or single-domain antibody to capsid protein IX. Poulin KL; Lanthier RM; Smith AC; Christou C; Risco Quiroz M; Powell KL; O'Meara RW; Kothary R; Lorimer IA; Parks RJ J Virol; 2010 Oct; 84(19):10074-86. PubMed ID: 20631131 [TBL] [Abstract][Full Text] [Related]
18. Substitution of blood coagulation factor X-binding to Ad5 by position-specific PEGylation: Preventing vector clearance and preserving infectivity. Krutzke L; Prill JM; Engler T; Schmidt CQ; Xu Z; Byrnes AP; Simmet T; Kreppel F J Control Release; 2016 Aug; 235():379-392. PubMed ID: 27302248 [TBL] [Abstract][Full Text] [Related]